Ушбу иш иқтибос қилган ишлар

161 та иш

Иш: Engineering CAR T NK and NKT cell therapies to target cancer stem cells and overcome stem like resistance

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Kevin Pan, Hizra Farrukh, Veera Chandra Sekhar Reddy Chittepu +3
Шарҳ мақола20223 иқтибос
ABI
Therapeutic effect of Chelidonium majus hydro-alcoholic extract alone and in combination with oxaliplatin on ovarian cancer cell line
Zahra Hashempour, Mehdi Noraddini, Majid Nejati +5
Мақола20253 иқтибос
ABI
Cancer stem cells and their niche in cancer progression and therapy
Qiuping Liu, Zongliang Guo, Guoyin Li +5
Шарҳ мақола20233 иқтибос
ABI
Programmed cell death and melatonin: A comprehensive review
Mahdi Rafiyian, Rüssel J. Reiter, Sayyed Mehdi Rasooli Manesh +5
Шарҳ мақола20243 иқтибос
ABI
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy
Andras Heczey, Daofeng Liu, Gengwen Tian +10
Мақола20143 иқтибос
ABI
Metabostemness: A New Cancer Hallmark
Javier A. Menéndez, TomÃ¡s AlarcÃ n
Шарҳ мақола20143 иқтибос
ABI
The Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain, Renier J. Brentjens, Isabelle Rivière
Шарҳ мақола20133 иқтибос
ABI
Targeting colorectal cancer (stem-like) cells using LGR5 directed antibody drug conjugates
Daniela Hirsch, Thomas Ried
Бошқа20163 иқтибос
ABI
Cancer stem cells revisited
Eduard Batlle, Hans Clevers
Шарҳ мақола20173 иқтибос
ABI
Engineering and Design of Chimeric Antigen Receptors
Sònia Guedan, Hugo Calderón, Avery D. Posey +1
Шарҳ мақола20183 иқтибос
ABI
Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
Rowa Y. Alhabbab
Шарҳ мақола20203 иқтибос
ABI
Dual Targeting with CAR T Cells to Limit Antigen Escape in Multiple Myeloma
Sylvain Simon, Stanley R. Riddell
Бошқа20203 иқтибос
ABI
Ferroptosis: molecular mechanisms and health implications
Daolin Tang, Xin Chen, Rui Kang +1
Шарҳ мақола20203 иқтибос
ABI
Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity
John P. Murad, Dileshni Tilakawardane, Anthony K. Park +15
Мақола20213 иқтибос
ABI
CAR-T Cell Therapy for Breast Cancer: From Basic Research to Clinical Application
Yu-Huan Yang, Jiawei Liu, Lü Chen +1
Шарҳ мақола20223 иқтибос
ABI
Cancer cell targeting by CAR-T cells: A matter of stemness
Caterina D’Accardo, Gaetana Porcelli, Laura Rosa Mangiapane +10
Шарҳ мақола20223 иқтибос
ABI
Enhancing clinical potential of liquid biopsy through a multi-omic approach: A systematic review
Gianna Di Sario, Valeria Rossella, Elvira Smeralda Famulari +4
Шарҳ мақола20233 иқтибос
ABI
Single-cell-guided identification of logic-gated antigen combinations for designing effective and safe CAR therapy
Sanna Madan, Tiangen Chang, Alexandra R. Harris +15
Препринт20253 иқтибос
ABI
Precision sniper for solid tumors: CAR-NK cell therapy
Sisi Li, Jiajie Jing, Yueming Chen +6
Шарҳ мақола20253 иқтибос
ABI
Optimization of metabolism to improve efficacy during CAR-T cell manufacturing
Meng Zhang, Xin Jin, Rui Sun +4
Шарҳ мақола20212 иқтибос
ABI
Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment
Ting Yan, Lingfeng Zhu, Jin Chen
Шарҳ мақола20232 иқтибос
ABI
Short‐chain acyl post‐translational modifications in cancers: Mechanisms, roles, and therapeutic implications
Ting Wu, Ying‐Qi Zhao, Xinming Zhang +14
Шарҳ мақола20252 иқтибос
ABI
Preclinical and clinical studies of CAR-NK-cell therapies for malignancies
Hongwen Li, Wenting Song, Zhaoming Li +1
Шарҳ мақола20222 иқтибос
ABI
VEGF‐FGF Signaling Activates Quiescent CD63<sup>+</sup> Liver Stem Cells to Proliferate and Differentiate
Fei Chen, Kunshan Zhang, Minjun Wang +12
Мақола20242 иқтибос
ABI
Small-molecule-induced liquid-liquid phase separation suppresses the carcinogenesis of β-catenin
Jin Yan, Heyuan Liu, Wenguang Yang +6
Мақола20252 иқтибос
ABI